Ditch those plastic packages

26th July 2020

Six inventions for protecting our food with materials that protect the environment, too…

View the article

Evox

EVOX THERAPEUTICS ANNOUNCES A MULTI-TARGET RNA INTERFERENCE AND ANTISENSE RESEARCH COLLABORATION AND LICENSE AGREEMENT WITH LILLY

9th June 2020

Evox to use its proprietary exosome loading and CNS-targeting technologies to develop oligonucleotide drugs for the treatment of neurological disorders…

View the article

TEMASEK LEADS TROPIC BIOSCIENCES' US$28.5m SERIES B ROUND

4th June 2020

Biotech startup Tropic Biosciences, which develops high-performance varieties of tropical crops, on Thursday said it has raised US$28.5 million in a Series B round led by Singapore state investment firm Temasek, bringing its total equity funding raised to US$40 million…

View the article

SIEMENS HEALTHINEERS TO EXPAND COVID-19 TESTING TO INCLUDE ANTIBODY TEST

1st May 2020

The antibody test, which has a potential time to result of 14 minutes, will join the rest of the company’s diagnostic portfolio…

View the article

MUSHROOMS WORK THEIR MAGIC AS INVESTORS SUPPORT COMPASS PATHWAYS START-UP

27th April 2020

A British start-up using the active ingredient in so-called magic mushrooms to treat clinical depression has raised $80 million from investors, including Peter Thiel, the billionaire Paypal co-founder and early Facebook investor…

View the article

Evox

EVOX THERAPEUTICS AND TAKEDA SIGN MULTI-TARGET RARE DISEASE COLLABORATION

26th March 2020

Collaboration focuses on developing novel protein replacement and mRNA therapies and explores the targeted delivery of these payloads using Evox’s proprietary exosome technology Partnership…

View the article

FORWARD ANNOUNCES LAUNCH OF COVID-19 HOME TESTING KITS

21st March 2020

With the offering of its first at-home testing kit, Forward expands COVID-19 testing options to scale its ability to treat the growing population experiencing the barricades of an overwhelmed healthcare system…

View the article

MAGIC MUSHROOM MEDICINE PASSES FIRST CLINICAL SAFETY TRIAL

11th December 2019

Psilocybin, the main psychoactive ingredient in magic mushrooms, has taken a step towards becoming a licensed treatment for depression, with the completion of the psychedelic chemical’s first controlled clinical study.

View the article

WITH LESSONS FROM HOSPITALITY AND TECH, FORWARD EXPANDS PRIMARY CARE FOOTPRINT ON EAST COAST

22nd July 2019

The newest primary care office in the nation’s capital opened just across the street from an upscale downtown development featuring luxury condos, designer boutiques from the likes of Carolina Herrera and a Tesla showroom.

View the article